Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Cardiovascular Event Rates Among Hemodialysis Patients Across Geographical Regions-A Snapshot From The Dialysis Outcomes and Practice Patterns Study (DOPPS).

Stirnadel-Farrant HA, Karaboyas A, Cizman B, Bieber BA, Kler L, Jones D, Cobitz AR, Robinson BM.

Kidney Int Rep. 2019 Mar 28;4(6):864-872. doi: 10.1016/j.ekir.2019.03.016. eCollection 2019 Jun.

2.

Patient-reported advantages and disadvantages of peritoneal dialysis: results from the PDOPPS.

Sukul N, Zhao J, Fuller DS, Karaboyas A, Bieber B, Sloand JA, Subramanian L, Johnson DW, Oliver MJ, Tungsanga K, Tomo T, Morton RL, Morgenstern H, Robinson BM, Perl J; clinical application of PD therapy working group.

BMC Nephrol. 2019 Apr 2;20(1):116. doi: 10.1186/s12882-019-1304-3.

3.

The association between longer haemodialysis treatment times and hospitalization and mortality after the two-day break in individuals receiving three times a week haemodialysis.

Fotheringham J, Sajjad A, Stel VS, McCullough K, Karaboyas A, Wilkie M, Bieber B, Robinson BM, Massy ZA, Jager KJ.

Nephrol Dial Transplant. 2019 Sep 1;34(9):1577-1584. doi: 10.1093/ndt/gfz007.

4.

The Association of Functional Status with Mortality and Dialysis Modality Change: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS).

Tennankore K, Zhao J, Karaboyas A, Bieber BA, Robinson BM, Morgenstern H, Jassal SV, Finkelstein FO, Kanjanabuch T, Cheawchanwattana A, Pisoni RL, Sloand JA, Perl J; PDOPPS patient support working group.

Perit Dial Int. 2019 Mar-Apr;39(2):103-111. doi: 10.3747/pdi.2018.00094. Epub 2019 Feb 9.

PMID:
30739094
5.

Associations between Hemodialysis Facility Practices to Manage Fluid Volume and Intradialytic Hypotension and Patient Outcomes.

Dasgupta I, Thomas GN, Clarke J, Sitch A, Martin J, Bieber B, Hecking M, Karaboyas A, Pisoni R, Port F, Robinson B, Rayner H.

Clin J Am Soc Nephrol. 2019 Mar 7;14(3):385-393. doi: 10.2215/CJN.08240718. Epub 2019 Feb 5.

PMID:
30723164
6.

Mineral and bone disorder management in hemodialysis patients: comparing PTH control practices in Japan with Europe and North America: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Yamamoto S, Karaboyas A, Komaba H, Taniguchi M, Nomura T, Bieber BA, De Sequera P, Christensson A, Pisoni RL, Robinson BM, Fukagawa M.

BMC Nephrol. 2018 Oct 5;19(1):253. doi: 10.1186/s12882-018-1056-5.

7.

Association between serum ferritin and mortality: findings from the USA, Japan and European Dialysis Outcomes and Practice Patterns Study.

Karaboyas A, Morgenstern H, Pisoni RL, Zee J, Vanholder R, Jacobson SH, Inaba M, Loram LC, Port FK, Robinson BM.

Nephrol Dial Transplant. 2018 Dec 1;33(12):2234-2244. doi: 10.1093/ndt/gfy190.

8.

The Authors Reply.

Hoshino J, Larkina M, Karaboyas A, Bieber B, Ubara Y, Takaichi K, Akizawa T, Akiba T, Fukuhara S, Pisoni RL, Saito A, Robinson BM.

Kidney Int. 2018 Jul;94(1):221-222. doi: 10.1016/j.kint.2018.04.018. No abstract available.

PMID:
29933850
9.

DOPPS data suggest a possible survival benefit of renin angiotensin-aldosterone system inhibitors and other antihypertensive medications for hemodialysis patients.

Karaboyas A, Xu H, Morgenstern H, Locatelli F, Jadoul M, Nitta K, Dasgupta I, Tentori F, Port FK, Robinson BM.

Kidney Int. 2018 Sep;94(3):589-598. doi: 10.1016/j.kint.2018.03.013. Epub 2018 Jun 13.

10.

Mortality risk in patients on hemodiafiltration versus hemodialysis: a 'real-world' comparison from the DOPPS.

Locatelli F, Karaboyas A, Pisoni RL, Robinson BM, Fort J, Vanholder R, Rayner HC, Kleophas W, Jacobson SH, Combe C, Port FK, Tentori F.

Nephrol Dial Transplant. 2018 Apr 1;33(4):683-689. doi: 10.1093/ndt/gfx277.

11.

Initiation of Sevelamer and Mortality among Hemodialysis Patients Treated with Calcium-Based Phosphate Binders.

Komaba H, Wang M, Taniguchi M, Yamamoto S, Nomura T, Schaubel DE, Smith AR, Zee J, Karaboyas A, Bieber B, Fukagawa M, Tentori F.

Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1489-1497. doi: 10.2215/CJN.13091216. Epub 2017 Jul 19.

12.

Unique hemoglobin A1c level distribution and its relationship with mortality in diabetic hemodialysis patients.

Hoshino J, Larkina M, Karaboyas A, Bieber BA, Ubara Y, Takaichi K, Akizawa T, Akiba T, Fukuhara S, Pisoni RL, Saito A, Robinson BM.

Kidney Int. 2017 Aug;92(2):497-503. doi: 10.1016/j.kint.2017.02.008. Epub 2017 Apr 8.

13.

Associations of employment status and educational levels with mortality and hospitalization in the dialysis outcomes and practice patterns study in Japan.

Imanishi Y, Fukuma S, Karaboyas A, Robinson BM, Pisoni RL, Nomura T, Akiba T, Akizawa T, Kurokawa K, Saito A, Fukuhara S, Inaba M.

PLoS One. 2017 Mar 6;12(3):e0170731. doi: 10.1371/journal.pone.0170731. eCollection 2017.

14.

Understanding associations of hemodialysis practices with clinical and patient-reported outcomes: examples from the DOPPS.

Port FK, Morgenstern H, Bieber BA, Karaboyas A, McCullough KP, Tentori F, Pisoni RL, Robinson BM.

Nephrol Dial Transplant. 2017 Apr 1;32(suppl_2):ii106-ii112. doi: 10.1093/ndt/gfw287. Review. No abstract available.

15.

Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Karaboyas A, Zee J, Brunelli SM, Usvyat LA, Weiner DE, Maddux FW, Nissenson AR, Jadoul M, Locatelli F, Winkelmayer WC, Port FK, Robinson BM, Tentori F.

Am J Kidney Dis. 2017 Feb;69(2):266-277. doi: 10.1053/j.ajkd.2016.09.015. Epub 2016 Nov 17.

16.

Association between changes in quality of life and mortality in hemodialysis patients: results from the DOPPS.

Perl J, Karaboyas A, Morgenstern H, Sen A, Rayner HC, Vanholder RC, Combe C, Hasegawa T, Finkelstein FO, Lopes AA, Robinson BM, Pisoni RL, Tentori F.

Nephrol Dial Transplant. 2017 Mar 1;32(3):521-527. doi: 10.1093/ndt/gfw233.

17.

Functional Dependence and Mortality in the International Dialysis Outcomes and Practice Patterns Study (DOPPS).

Jassal SV, Karaboyas A, Comment LA, Bieber BA, Morgenstern H, Sen A, Gillespie BW, De Sequera P, Marshall MR, Fukuhara S, Robinson BM, Pisoni RL, Tentori F.

Am J Kidney Dis. 2016 Feb;67(2):283-92. doi: 10.1053/j.ajkd.2015.09.024. Epub 2015 Nov 21.

18.

Understanding the Recent Increase in Ferritin Levels in United States Dialysis Patients: Potential Impact of Changes in Intravenous Iron and Erythropoiesis-Stimulating Agent Dosing.

Karaboyas A, Zee J, Morgenstern H, Nolen JG, Hakim R, Kalantar-Zadeh K, Zager P, Pisoni RL, Port FK, Robinson BM.

Clin J Am Soc Nephrol. 2015 Oct 7;10(10):1814-21. doi: 10.2215/CJN.02600315. Epub 2015 Aug 18.

19.

Phosphate binder pill burden, patient-reported non-adherence, and mineral bone disorder markers: Findings from the DOPPS.

Fissell RB, Karaboyas A, Bieber BA, Sen A, Li Y, Lopes AA, Akiba T, Bommer J, Ethier J, Jadoul M, Pisoni RL, Robinson BM, Tentori F.

Hemodial Int. 2016 Jan;20(1):38-49. doi: 10.1111/hdi.12315. Epub 2015 May 14.

20.

Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.

Tentori F, Wang M, Bieber BA, Karaboyas A, Li Y, Jacobson SH, Andreucci VE, Fukagawa M, Frimat L, Mendelssohn DC, Port FK, Pisoni RL, Robinson BM.

Clin J Am Soc Nephrol. 2015 Jan 7;10(1):98-109. doi: 10.2215/CJN.12941213. Epub 2014 Dec 16.

21.

Dialysate bicarbonate and the risk of death.

Tentori F, Morgenstern H, Karaboyas A, Robinson BM, Port FK.

Semin Dial. 2014 Sep-Oct;27(5):505. doi: 10.1111/sdi.12253. No abstract available.

22.

Association between allopurinol and mortality among Japanese hemodialysis patients: results from the DOPPS.

Tsuruta Y, Nitta K, Akizawa T, Fukuhara S, Saito A, Karaboyas A, Li Y, Port FK, Robinson BM, Pisoni RL, Akiba T.

Int Urol Nephrol. 2014 Sep;46(9):1833-41. doi: 10.1007/s11255-014-0731-0. Epub 2014 Jun 8.

23.

Dialysate sodium prescription and blood pressure in hemodialysis patients.

Hecking M, Karaboyas A, Rayner H, Saran R, Sen A, Inaba M, Bommer J, Hörl WH, Pisoni RL, Robinson BM, Sunder-Plassmann G, Port FK.

Am J Hypertens. 2014 Sep;27(9):1160-9. doi: 10.1093/ajh/hpu040. Epub 2014 Mar 20.

PMID:
24651636
24.

Potassium-binding resins: Associations with serum chemistries and interdialytic weight gain in hemodialysis patients.

Jadoul M, Karaboyas A, Goodkin DA, Tentori F, Li Y, Labriola L, Robinson BM.

Am J Nephrol. 2014;39(3):252-9. doi: 10.1159/000360094. Epub 2014 Mar 8.

25.

Association of blood pressure with all-cause mortality and stroke in Japanese hemodialysis patients: the Japan Dialysis Outcomes and Practice Pattern Study.

Inaba M, Karaboyas A, Akiba T, Akizawa T, Saito A, Fukuhara S, Combe C, Robinson BM.

Hemodial Int. 2014 Jul;18(3):607-15. doi: 10.1111/hdi.12156. Epub 2014 Mar 14.

PMID:
24629041
26.

Gender, low Kt/V, and mortality in Japanese hemodialysis patients: opportunities for improvement through modifiable practices.

Kimata N, Karaboyas A, Bieber BA, Pisoni RL, Morgenstern H, Gillespie BW, Saito A, Akizawa T, Fukuhara S, Robinson BM, Port FK, Akiba T.

Hemodial Int. 2014 Jul;18(3):596-606. doi: 10.1111/hdi.12142. Epub 2014 Feb 24.

27.

Current evidence argues against lowering the dialysate sodium.

Port F, Hecking M, Karaboyas A, Pisoni R, Robinson B.

Nephrol News Issues. 2013 Dec;27(13):18-21. No abstract available.

PMID:
24597066
28.

Recovery time, quality of life, and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Rayner HC, Zepel L, Fuller DS, Morgenstern H, Karaboyas A, Culleton BF, Mapes DL, Lopes AA, Gillespie BW, Hasegawa T, Saran R, Tentori F, Hecking M, Pisoni RL, Robinson BM.

Am J Kidney Dis. 2014 Jul;64(1):86-94. doi: 10.1053/j.ajkd.2014.01.014. Epub 2014 Feb 14.

29.

The authors reply.

Kleophas W, Karaboyas A, Li Y, Bommer J, Reichel H, Walter A, Icks A, Rump LC, Pisoni RL, Robinson BM, Port FK.

Kidney Int. 2013 Nov;84(5):1051-2. doi: 10.1038/ki.2013.315. No abstract available.

30.

Associations of frequency and duration of patient-doctor contact in hemodialysis facilities with mortality.

Kawaguchi T, Karaboyas A, Robinson BM, Li Y, Fukuhara S, Bieber BA, Rayner HC, Andreucci VE, Pisoni RL, Port FK, Morgenstern H, Akizawa T, Saran R.

J Am Soc Nephrol. 2013 Sep;24(9):1493-502. doi: 10.1681/ASN.2012080831. Epub 2013 Jul 25.

31.

Significance of interdialytic weight gain versus chronic volume overload: consensus opinion.

Hecking M, Karaboyas A, Antlanger M, Saran R, Wizemann V, Chazot C, Rayner H, Hörl WH, Pisoni RL, Robinson BM, Sunder-Plassmann G, Moissl U, Kotanko P, Levin NW, Säemann MD, Kalantar-Zadeh K, Port FK, Wabel P.

Am J Nephrol. 2013;38(1):78-90. doi: 10.1159/000353104. Epub 2013 Jul 6.

32.

Association of dialysate bicarbonate concentration with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Tentori F, Karaboyas A, Robinson BM, Morgenstern H, Zhang J, Sen A, Ikizler TA, Rayner H, Fissell RB, Vanholder R, Tomo T, Port FK.

Am J Kidney Dis. 2013 Oct;62(4):738-46. doi: 10.1053/j.ajkd.2013.03.035. Epub 2013 May 24.

33.

Glucose metabolism after renal transplantation.

Hecking M, Kainz A, Werzowa J, Haidinger M, Döller D, Tura A, Karaboyas A, Hörl WH, Wolzt M, Sharif A, Roden M, Moro E, Pacini G, Port FK, Säemann MD.

Diabetes Care. 2013 Sep;36(9):2763-71. doi: 10.2337/dc12-2441. Epub 2013 May 8.

34.

Changes in dialysis treatment modalities during institution of flat rate reimbursement and quality assurance programs.

Kleophas W, Karaboyas A, Li Y, Bommer J, Reichel H, Walter A, Icks A, Rump LC, Pisoni RL, Robinson BM, Port FK.

Kidney Int. 2013 Sep;84(3):578-84. doi: 10.1038/ki.2013.143. Epub 2013 May 1.

35.

Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Tentori F, Zhang J, Li Y, Karaboyas A, Kerr P, Saran R, Bommer J, Port F, Akiba T, Pisoni R, Robinson B.

Nephrol Dial Transplant. 2012 Nov;27(11):4180-8. doi: 10.1093/ndt/gfs021. Epub 2012 Mar 19.

36.

Dialysate sodium concentration and the association with interdialytic weight gain, hospitalization, and mortality.

Hecking M, Karaboyas A, Saran R, Sen A, Inaba M, Rayner H, Hörl WH, Pisoni RL, Robinson BM, Sunder-Plassmann G, Port FK.

Clin J Am Soc Nephrol. 2012 Jan;7(1):92-100. doi: 10.2215/CJN.05440611. Epub 2011 Nov 3.

37.

Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Hecking M, Karaboyas A, Saran R, Sen A, Hörl WH, Pisoni RL, Robinson BM, Sunder-Plassmann G, Port FK.

Am J Kidney Dis. 2012 Feb;59(2):238-48. doi: 10.1053/j.ajkd.2011.07.013. Epub 2011 Sep 23.

PMID:
21944663
38.

Uric acid levels and all-cause and cardiovascular mortality in the hemodialysis population.

Latif W, Karaboyas A, Tong L, Winchester JF, Arrington CJ, Pisoni RL, Marshall MR, Kleophas W, Levin NW, Sen A, Robinson BM, Saran R.

Clin J Am Soc Nephrol. 2011 Oct;6(10):2470-7. doi: 10.2215/CJN.00670111. Epub 2011 Aug 25.

39.

Clinical practices and outcomes in elderly hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Canaud B, Tong L, Tentori F, Akiba T, Karaboyas A, Gillespie B, Akizawa T, Pisoni RL, Bommer J, Port FK.

Clin J Am Soc Nephrol. 2011 Jul;6(7):1651-62. doi: 10.2215/CJN.03530410.

Supplemental Content

Loading ...
Support Center